Importantly, these medications carry a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2
The peptide's extended half-life distinguishes it from earlier amylin analogues
The roller coaster ride to the first GLP-1 obesity drug While approved first as a drug for diabetes, very early on in its development, when Knudsen first began work on liraglutide she wondered if the same drug could also be used as a treatment of obesity (Molteni, Chen)
Who should skip GLP-1 supplements People with significant weight-related health risks, including type 2 diabetes, cardiovascular disease, or obesity-related complications, should not rely on supplements when pharmaceutical options exist that produce faster, stronger, better-documented results